RMD
RESMED INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$237.75
+4.70%Next report
Analyst consensus
- Next report date
- Jan 28, 2027
- EPS estimate
- $3.02
- Revenue estimate
- $1.5B
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- $2.91
- EPS estimate
- $2.70
- Revenue actual
- $1.4B
- Revenue estimate
- $1.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +3.7%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $257
- PT range
- $225 – $288
- Analysts
- 7
2 Buy5 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | $2.70 | $2.91 | Beat 7.94% | $1.4B |
| Aug 6, 2026 | $2.89 | $2.95 | Beat 1.97% | $1.5B |
| Apr 30, 2026 | $2.79 | $2.86 | Beat 2.55% | $1.4B |
| Jan 29, 2026 | $2.74 | $2.81 | Beat 2.44% | $1.4B |
| Oct 30, 2025 | $2.51 | $2.55 | Beat 1.43% | $1.3B |
| Jul 31, 2025 | $2.55 | $2.55 | Miss -0.04% | $1.3B |
| Apr 23, 2025 | $2.39 | $2.37 | Miss -0.75% | $1.3B |
| Jan 30, 2025 | $2.32 | $2.43 | Beat 4.70% | $1.3B |
| Oct 24, 2024 | $2.04 | $2.20 | Beat 7.90% | $1.2B |
| Aug 1, 2024 | $2.06 | $2.08 | Beat 0.73% | $1.2B |
| Apr 25, 2024 | $1.91 | $2.13 | Beat 11.52% | $1.2B |
| Jan 24, 2024 | $1.81 | $1.88 | Beat 3.75% | $1.2B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jan 28, 2027